Literature DB >> 1124954

Virus antibodies in serum and synovial fluid of patients with rheumatoid arthritis and other connective tissue diseases.

J L Kalliomäki, P Halonen, A Salmi.   

Abstract

Rubella and influenza A (H3N2) haemagglutination inhibition (HI) antibody titres and measles complement-fixing (CF), haemagglutination inhibition (HI), haemolysis inhibition (HLI), and ribonucleoprotein gel precipitation (RNP-GP) antibody titres were studied in the serum and synovial fluid of twenty patients with rheumatoid arthritis (RA), two patients with ankylosing spondylitis, and two patients with Reiter's syndrome. Antibody titres were also studied in the serum and CSF of four patients with systemic lupus erythematosus (SLE), one patient with dermatomyositis, and in the synovial fluid only of five patients with osteoarthritic knee effusions. Antibodies were found with each serological technique used in the synovial fluid of RA patients and the antibody titres were usually at about the same level as in the serum. The mean measles (HI, HLI, and RNP-GP) antibody titres were 4 to 6 times higher in the synovial fluid of RA patients than in synovial fluid of patients with osteoarthritic knee effusions, but a corresponding difference was not found in rubella and influenza A antibody titres. The mean measles antibody titres (CF, HI, HKI, and RNP-GP) were consistently higher in the synovial fluid of RA patients without rheumatoid factor than in the synovial fluid of RA patients with rheumatoid factor. In serum this difference was observed only with measles CF titres. The mean measles, antibody titres were consistently lower in the serum and synovial fluid of the RA patients without the synovial fluid haemolytic complement than in the RA patients with this haemolytic complement. No similar differences were found in the rubella and influenza antibody titres. No significant measles antibody titres were found in the CSF of patients with SLE or dermatomyositis.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1124954      PMCID: PMC1006343          DOI: 10.1136/ard.34.1.43

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  17 in total

1.  Letter: Negative complement-fixation tests as an immunopathological finding.

Authors:  K Penttinen; O Wager; S Pyrhönen; P Leinikki; A M Teppo
Journal:  Lancet       Date:  1974-03-02       Impact factor: 79.321

2.  Letter: Suppressed cellular immunity to measles antigen in multiple-sclerosis patients.

Authors:  V Utermohlen; J B Zabriskie
Journal:  Lancet       Date:  1973-11-17       Impact factor: 79.321

3.  Very high measles and rubella virus antibody titres associated with hepatitis, systemic lupus erythematosus, and infectious mononucleosis.

Authors:  O Laitinen; A Vaheri
Journal:  Lancet       Date:  1974-02-09       Impact factor: 79.321

4.  Letter: Lack of antigen response to myxoviruses in multiple sclerosis.

Authors:  A K Ciongoli; P Platz; B Dupont; A Svejgaard; T Fog; C Jersild
Journal:  Lancet       Date:  1973-11-17       Impact factor: 79.321

5.  Measles antibodies in sera from patients with autoimmune diseases.

Authors:  C J Lucas; R Brouwer; T E Feltkamp; J H ten Veen; J J van Loghem
Journal:  Lancet       Date:  1972-01-15       Impact factor: 79.321

6.  Immunoglobulins and measles antibodies in subacute sclerosing panencephalitis.

Authors:  H Link; M Panelius; A A Salmi
Journal:  Arch Neurol       Date:  1973-01

7.  Comparison of complement-fixing antibody titres in patients with rheumatoid arthritis and matched controls.

Authors:  F Stanford
Journal:  Ann Rheum Dis       Date:  1972-07       Impact factor: 19.103

8.  Measles antibodies detected with various techniques in sera of patients with multiple sclerosis.

Authors:  M Panelius; A A Salmi; P Halonen; K Penttinen
Journal:  Acta Neurol Scand       Date:  1971       Impact factor: 3.209

9.  Appearance and persistence of antibodies against different virus components after regular measles infections.

Authors:  E Norrby; Y Gollmar
Journal:  Infect Immun       Date:  1972-09       Impact factor: 3.441

10.  Measles virus antibody in cerebrospinal fluids from patients with multiple sclerosis.

Authors:  A A Salmi; M Panelius; P Halonen; U K Rinne; K Penttinen
Journal:  Br Med J       Date:  1972-02-19
View more
  10 in total

1.  Local synovial synthesis of oligoclonal measles virus antibodies and of smooth muscle antibodies in a case of atypical rheumatoid arthritis.

Authors:  B Vandvik; O J Mellbye; E Norrby
Journal:  Ann Rheum Dis       Date:  1977-08       Impact factor: 19.103

Review 2.  Rheumatoid arthritis: review of searches for an infectious cause. Part II.

Authors:  E Wilkes; E S Meek
Journal:  Infection       Date:  1979       Impact factor: 3.553

3.  Antibodies specific for measles virus envelope antigens and autoantibodies in patients with chronic active hepatitis.

Authors:  P V Shirodaria; S A McMillan; M E Callender; M Haire; E Fleming; J D Merrett; T T Fulton
Journal:  J Clin Pathol       Date:  1985-11       Impact factor: 3.411

4.  Effect of drug therapy on circulating and synovial fluid Ig-secreting cells in rheumatoid arthritis.

Authors:  S Al-Balaghi; H Ström; E Möller
Journal:  Ann Rheum Dis       Date:  1985-04       Impact factor: 19.103

5.  Measles antibodies and autoantibodies in autoimmune disorders.

Authors:  D R Triger; T R Gamlen; E Paraskevas; R S Lloyd; R Wright
Journal:  Clin Exp Immunol       Date:  1976-06       Impact factor: 4.330

Review 6.  Etiology of rheumatoid arthritis.

Authors:  T Kouri
Journal:  Experientia       Date:  1985-04-15

7.  Association of Sinusitis and Upper Respiratory Tract Diseases With Incident Rheumatoid Arthritis: A Case-control Study.

Authors:  Vanessa L Kronzer; Weixing Huang; Alessandra Zaccardelli; Cynthia S Crowson; John M Davis; Robert Vassallo; Tracy J Doyle; Elena Losina; Jeffrey A Sparks
Journal:  J Rheumatol       Date:  2021-10-15       Impact factor: 4.666

8.  Measles virus-specific antibodies and immunoglobulin M antiglobulin in sera from multiple sclerosis and rheumatoid arthritis patients.

Authors:  P V Shirodaria; K B Fraser; M Armstrong; S D Roberts
Journal:  Infect Immun       Date:  1979-07       Impact factor: 3.441

9.  Correlative studies of rheumatoid factors and anti-viral antibodies in patients with rheumatoid arthritis.

Authors:  A S Ferraro; M M Newkirk
Journal:  Clin Exp Immunol       Date:  1993-06       Impact factor: 4.330

10.  Measles contributes to rheumatoid arthritis: evidence from pathway and network analyses of genome-wide association studies.

Authors:  Guiyou Liu; Yongshuai Jiang; Xiaoguang Chen; Ruijie Zhang; Guoda Ma; Rennan Feng; Liangcai Zhang; Mingzhi Liao; Yingbo Miao; Zugen Chen; Rong Zeng; Keshen Li
Journal:  PLoS One       Date:  2013-10-18       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.